Current Rheumatology Reviews

Scope & Guideline

Empowering researchers with comprehensive rheumatology insights.

Introduction

Delve into the academic richness of Current Rheumatology Reviews with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1573-3971
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2006 to 2024
AbbreviationCURR RHEUMATOL REV / Curr. Rheumatol. Rev.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

Current Rheumatology Reviews focuses on advancing the understanding of rheumatic diseases through innovative research, clinical insights, and therapeutic strategies. The journal aims to integrate basic science with clinical practice, providing a comprehensive platform for researchers and clinicians alike.
  1. Clinical Management of Rheumatic Diseases:
    The journal emphasizes research on the diagnosis, management, and treatment of various rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, and more. It aims to address both traditional and novel therapeutic approaches.
  2. Genetic and Molecular Insights:
    Research articles frequently explore genetic polymorphisms, biomarkers, and molecular mechanisms underlying rheumatic diseases, contributing to a better understanding of disease pathogenesis and potential targets for therapy.
  3. Patient Quality of Life and Health Outcomes:
    A significant focus is placed on studies assessing the impact of rheumatic diseases on patients' quality of life, functional ability, and psychological well-being, highlighting the importance of holistic patient care.
  4. Emerging Therapies and Innovative Treatments:
    The journal covers novel therapeutic strategies, including biologics, small molecules, and complementary approaches, providing insights into the latest advancements in treatment options for rheumatic conditions.
  5. Epidemiological Studies and Public Health:
    Current Rheumatology Reviews includes epidemiological research that examines the prevalence, risk factors, and health disparities related to rheumatic diseases, contributing to public health knowledge and policy.
Current Rheumatology Reviews has identified several emerging themes and trends that reflect the evolving landscape of rheumatology research and clinical practice, highlighting areas of increasing interest.
  1. Precision Medicine and Personalized Therapy:
    There is a growing emphasis on precision medicine approaches, exploring how genetic, environmental, and lifestyle factors can be integrated into personalized treatment plans for patients with rheumatic diseases.
  2. Impact of COVID-19 on Rheumatic Diseases:
    The journal has seen a surge in research exploring the effects of COVID-19 on patients with rheumatic conditions, including disease activity and treatment responses, reflecting the pandemic's profound impact on healthcare.
  3. Role of the Microbiome in Rheumatic Diseases:
    Emerging studies are increasingly investigating the connections between the microbiome and autoimmune diseases, suggesting a novel area of research that may lead to innovative therapeutic strategies.
  4. Use of Digital Health Technologies:
    The integration of digital health technologies, such as telemedicine and mobile health applications, is becoming a prominent theme, focusing on improving patient management and access to care.
  5. Interdisciplinary Approaches to Rheumatology:
    There is a trend towards interdisciplinary research that combines rheumatology with other fields such as neurology, cardiology, and endocrinology, addressing the complex interplay of comorbidities in rheumatic diseases.

Declining or Waning

While Current Rheumatology Reviews has maintained a robust focus on various aspects of rheumatology, certain themes have shown a decline in publication frequency over recent years, indicating shifting research priorities.
  1. Traditional Therapies and Older Treatments:
    There has been a noticeable decrease in studies focusing on older treatment modalities, such as non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, as newer therapies gain prominence.
  2. Aging-Related Rheumatic Conditions:
    Research specifically addressing aging-related rheumatic conditions has waned, suggesting a shift towards more contemporary issues in rheumatology such as autoimmunity and genetic predispositions.
  3. Basic Science Research:
    There is a declining trend in purely basic science studies that do not directly connect to clinical applications, as the journal increasingly emphasizes translational research that links laboratory findings to patient care.
  4. Generalized Epidemiological Surveys:
    While epidemiological research remains important, there appears to be a decline in generalized surveys that do not focus on specific populations or diseases, favoring more targeted studies.

Similar Journals

Modern Rheumatology

Elevating Standards in Rheumatologic Practice
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Egyptian Rheumatologist

Illuminating the path to improved patient outcomes.
Publisher: ELSEVIERISSN: 1110-1164Frequency: 4 issues/year

The Egyptian Rheumatologist is a peer-reviewed Open Access journal dedicated to advancing the field of rheumatology. Published by Elsevier since 2011, the journal aims to disseminate high-quality research, clinical innovations, and reviews that cover a wide range of topics related to autoimmune diseases, arthritis, and musculoskeletal disorders. With an ISSN of 1110-1164 and an E-ISSN of 2090-2433, it has achieved a respectable rank of #50 out of 73 in the medicine/rheumatology category according to Scopus, positioning it in the 32nd percentile among its peers. Operating from its base in Amsterdam, Netherlands, the journal provides an accessible platform for researchers, professionals, and students, encouraging a collaborative exchange of cutting-edge knowledge that is essential for the ongoing developments in rheumatologic care and research. The Open Access model ensures that critical findings and advancements are available to a global audience, fostering further research and education within this vital field.

Reumatologia Clinica

Elevating the standard of care in rheumatology.
Publisher: ELSEVIER ESPANA SLUISSN: 1699-258XFrequency: 6 issues/year

Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.

LUPUS

Pioneering innovative research in lupus and beyond.
Publisher: SAGE PUBLICATIONS LTDISSN: 0961-2033Frequency: 14 issues/year

LUPUS is a premier peer-reviewed journal published by SAGE Publications Ltd, focusing on the field of rheumatology, with a specific emphasis on the complexities of lupus and related autoimmune disorders. Since its inception in 1991, the journal has consistently ranked in the Q2 category within the rheumatology field, currently positioned as #29 out of 73 in Scopus, reflecting its significant contributions to research and clinical practice. The journal aims to foster a deeper understanding of lupus through the publication of original research articles, reviews, and clinical studies, making it an essential resource for researchers, clinicians, and students dedicated to advancing knowledge in this vital area of medicine. With an impact factor that underscores its influence, LUPUS serves as a critical platform for sharing innovative findings and engaging discussions within the global scientific community. Although the journal follows a traditional access model, it is situated in the United Kingdom, at 1 Olivers Yard, 55 City Road, London EC1Y 1SP, England, and remains dedicated to supporting the continuous advancement of research in autoimmune diseases.

European Journal of Rheumatology

Advancing Insights in Rheumatology Research
Publisher: AVESISSN: 2147-9720Frequency: 4 issues/year

European Journal of Rheumatology is a premier, peer-reviewed journal that has been paving the way for innovative research and in-depth analysis in the field of rheumatology since its launch. Published by AVES, this Open Access journal has been accessible to researchers, professionals, and students worldwide since 2014, promoting the sharing of valuable knowledge on rheumatic diseases and their treatment. With an ISSN of 2147-9720 and an E-ISSN of 2148-4279, it provides a prominent platform for groundbreaking studies and clinical evaluations that bridge scientific discovery with practical application. The journal’s mission is to enhance the understanding of rheumatological conditions and facilitate advancements in therapeutic strategies, making it an essential resource for anyone devoted to the improvement of patient care in this dynamic field. The European Journal of Rheumatology is committed to upholding the highest standards of scholarly publishing and aims to foster collaboration among researchers and practitioners across Europe and beyond.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Pioneering insights for the future of patient care.
Publisher: CLINICAL & EXPER RHEUMATOLOGYISSN: 0392-856XFrequency: 6 issues/year

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.

Indian Journal of Rheumatology

Advancing knowledge in rheumatology, one article at a time.
Publisher: SAGE PUBLICATIONS INCISSN: 0973-3698Frequency: 4 issues/year

Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.

Journal of Rheumatic Diseases

Innovating research and practice in rheumatic diseases.
Publisher: KOREAN COLL RHEUMATOLOGYISSN: 2093-940XFrequency: 4 issues/year

Journal of Rheumatic Diseases, published by the Korean College of Rheumatology, stands as a pivotal platform in the field of rheumatology, contributing significantly to the advancement of knowledge and clinical practice since its inception. With an impact factor reflecting its esteemed position in the academic community, this open-access journal promotes accessibility to high-quality research, ensuring that groundbreaking discoveries are reachable to all stakeholders in the realm of rheumatic diseases. The journal has maintained its commitment to quality, evidenced by its ranking in the Q3 category for Rheumatology in 2023, and its presence among the top quartiles of medical research. Focusing on innovative therapeutic approaches, emerging diagnostic techniques, and comprehensive reviews, the Journal of Rheumatic Diseases seeks to foster collaboration and dialogue among researchers, clinicians, and students alike. For accessibility, the journal offers numerous articles since its transition to open access in 2017, thereby facilitating research dissemination across the globe. As it converges over the years from 2019 to 2024, the journal promises to be instrumental in shaping the future of rheumatic disease research, inviting contributions that inspire new frontiers in this essential field.

Rheumatology and Therapy

Unlocking the future of rheumatology and therapy.
Publisher: SPRINGERISSN: 2198-6576Frequency: 4 issues/year

Rheumatology and Therapy, published by Springer, stands as a prominent open-access journal within the fields of Immunology and Allergy and Rheumatology. Since its inception in 2014, the journal has made significant contributions to advancing the understanding, diagnosis, and treatment of rheumatic diseases, garnering a solid reputation with an impact factor that reflects its rigorous peer-review process and scholarly influence. Currently ranked in the Q2 quartile for both its categories according to 2023 metrics, it occupies a significant position among its peers, standing at Rank #21 out of 73 in Medicine Rheumatology and Rank #101 out of 233 for Medicine Immunology and Allergy. The journal's scope encompasses cutting-edge research, reviews, and clinical studies that aim to bridge the gap between laboratory findings and patient care, making it an invaluable resource for researchers, clinicians, and students alike. With its commitment to open access, Rheumatology and Therapy ensures that high-quality research is available to a global audience, fostering collaboration and innovation in rheumatology and immunology. To learn more, visit their official site and explore the wealth of knowledge available.

Archives of Rheumatology

Advancing knowledge in rheumatology for a healthier future.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.